Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – MENAFN.COM
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell ImmunityVancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology…
(MENAFN – Newsfile Corp) BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related…
-
Noosa News16 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoAbout 90,000 households remain without power after severe storms with giant hail lash south-east Queensland
-
General17 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General19 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility